ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Melanotransferrin
Clear All
Filter by Field of Research
Cell Metabolism (2)
Basic Pharmacology (1)
Medical and Health Sciences (1)
Medical biochemistry - carbohydrates (1)
Pathology (1)
Pharmacology and Pharmaceutical Sciences (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (7)
Filter by Status
Closed (7)
Filter by Scheme
NHMRC Project Grants (4)
NHMRC Research Fellowships (2)
Project Grants (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
ACT (2)
NSW (2)
WA (1)
  • Researchers (0)
  • Funded Activities (7)
  • Organisations (0)
  • Funded Activity

    The Role Of Tumour Antigen, Melanotransferrin, In Iron Uptake By Human Melanoma Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $177,677.00
    More information
    Funded Activity

    The Physiological And Pathophysiological Roles Of Melanotransferrin

    Funder
    National Health and Medical Research Council
    Funding Amount
    $513,437.00
    Summary
    Melanotransferrin (MTf) is a membrane-bound molecule that was originally identified at very high levels in malignant melanoma cells and other tumours. To our surprise, our recent studies showed that MTf was also widely expressed in normal tissues (DR EJB 2000). MTf has many similarities to the iron (Fe)-binding protein, transferrin (Tf), and initially, MTf was thought to play a critical role in Fe uptake that is crucial for DNA synthesis. However, we demonstrated that MTf did not play a major ro .... Melanotransferrin (MTf) is a membrane-bound molecule that was originally identified at very high levels in malignant melanoma cells and other tumours. To our surprise, our recent studies showed that MTf was also widely expressed in normal tissues (DR EJB 2000). MTf has many similarities to the iron (Fe)-binding protein, transferrin (Tf), and initially, MTf was thought to play a critical role in Fe uptake that is crucial for DNA synthesis. However, we demonstrated that MTf did not play a major role in Fe uptake by melanoma cells (DR 1990, 1991a,b, 2000). We also showed that the tissue distribution of MTf was very different to Tf and the Tf-receptor 1 (TfR1) that are well known to be involved in Fe transport. For instance, TfR1 is highly expressed in tissues with large Fe needs (e.g., placenta), while MTf is not expressed at high levels in these tissues and is found in unexpected locations (i.e., salivary gland). In contrast to expectations, MTf was also found at higher levels in normal than foetal tissue. Also interesting was the finding that MTf is found in the serum and brain of Alzheimer's disease patients. Over the last 2 years under our current NHMRC grant on MTf we have significantly extended our knowledge on this molecule. As proposed in this grant, we generated a MTf knockout mouse. This is a very exciting model that is the best way of determining the function of MTf. Furthermore, we used recombinant MTf to show that soluble MTf that is found in the plasma is not an effective Fe donor to cells (DR EJB 2002). Our results over the last 12 years indicate that MTf may play unexpected biological roles (see DR FEBS Lett 2000). For the first time, generation of our MTf knockout mouse will provide the exciting opportunity of characterising its role(s). This will be important in understanding the function of MTf in cancer cells, Alzheimer's disease and in other tissues (eg., salivary gland and kidney) where it is expressed at high levels.
    Read more Read less
    More information
    Funded Activity

    The Role Of Melanoma Tumour Antigen P97 (Melanotransferrin) In Melanoma Tumourigenesis.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $563,242.00
    Summary
    The Role of Melanoma Tumour Antigen p97 (Melanotransferrin) in Melanoma Tumourigenesis Melanotransferrin (MTf) is a homologue of the iron transport protein, transferrin, and was one of the first well characterised melanoma tumour antigens. Our published studies have shown that MTf plays an important role in melanoma tumourigenesis in vivo. In this proposal, we will assess if it is associated with melanoma progression in patient samples and examine its role in melanoma growth and metastasis.
    More information
    Funded Activity

    Melanotransferrin: A “Missing Link” And A Novel Pharmacological Target For Treatment

    Funder
    National Health and Medical Research Council
    Funding Amount
    $613,848.00
    Summary
    Despite >30 years of research, the precise function of the protein, melanotransferrin (MTf), is unknown. However, we have breakthrough evidence that MTf stimulates WNT signalling as a major driver in cancer progression. We will investigate this hypothesis, which will underpin new cancer therapies. Indeed, we designed a new class of drugs that target the WNT pathway via up-regulating the WNT inhibitor, NDRG1. This drug (DpC) inhibits MTf expression to block tumour cell growth and metastasis.
    More information
    Funded Activity

    The Physiological And Pathophysiological Roles Of Melanotransferrin

    Funder
    National Health and Medical Research Council
    Funding Amount
    $227,485.00
    Summary
    Melanotransferrin (MTf) is a membrane bound molecule that was originally identified in the malignant melanoma skin cancer and other tumours. Interestingly, MTf has many similarities to the serum iron-binding protein, transferrin, and initially MTf was thought to play a role in iron uptake by these cells. However, a series of studies by the applicant demonstrated that MTf did not play a major role in iron uptake by melanoma cells (Richardson et al. 1990, 1991a,b). In fact, most iron taken up by t .... Melanotransferrin (MTf) is a membrane bound molecule that was originally identified in the malignant melanoma skin cancer and other tumours. Interestingly, MTf has many similarities to the serum iron-binding protein, transferrin, and initially MTf was thought to play a role in iron uptake by these cells. However, a series of studies by the applicant demonstrated that MTf did not play a major role in iron uptake by melanoma cells (Richardson et al. 1990, 1991a,b). In fact, most iron taken up by these cells was via the binding of transferrin to the transferrin receptor. More recently, under the current NHMRC grant, we have been able to confirm and signficantly extend our previous studies to convincingly show that MTf is not involved in iron uptake by melanoma cells where it is expressed at very high levels (Richardson 2000 Eur. J. Biochem. 267 (in press). In addition, we showed that the expression of MTf in 50 human tissues was very different to transferrin and the transferrin receptor (TfR) that are well known to be involved in iron transport. For example, the TfR is expressed at high levels in tissues that require large amounts of iron eg. the placenta and bone marrow. In contrast, MTf was not expressed at high levels in these tissues, but was found in large amounts in unexpected locations such as the salivary gland. Furthermore, the expression of MTf was widespread through a variety of tissues, and in contrast to expectations, was found at higher levels in normal rather than fetal tissues. It is also intesting that MTf is found in the blood and brain of Alzheimer's disease patients. Our results suggest that MTf may play other unexpected roles apart from iron uptake. The present proposal will assess the roles of MTf in cellular functioning. This information will be very important in understanding the function of MTf in cancer cells, Alzheimer's disease and also in other tissues (eg. the salivary gland) where it is expressed at very high levels.
    Read more Read less
    More information
    Funded Activity

    Uncoupled Research Fellowship

    Funder
    National Health and Medical Research Council
    Funding Amount
    $794,641.00
    Summary
    I am a pharmacologist-cell biologist-molecular biologist and chemist examining the metabolism of iron in normal and neoplastic cells and the development of iron chelators for the treatment of a wide variety of diseases eg., ?-thalassaemia, cancer and Frie
    More information
    Funded Activity

    Research Fellowship - Grant ID:457090

    Funder
    National Health and Medical Research Council
    Funding Amount
    $263,250.00
    Summary
    I am a pharmacologist-cell biologist-molecular biologist and chemist examining the metabolism of iron in normal and neoplastic cells and the development of iron chelators for the treatment of a variety of diseases e.g., ?-thalassaemia and cancer.
    More information

    Showing 1-7 of 7 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback